SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9629	Companies
191456	Keywords
122915	Articles
102031	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 05/31/2024 at 12:00, 1 year 7 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF

published on 05/31/2024 at 07:10, 1 year 7 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 1 year 7 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 1 year 7 months ago

Sanofi Completes Acquisition of Inhibrx, Inc.

Acquisition Sanofi Rare Diseases Inhibrx SAR447537
PRESS RELEASE

published on 05/30/2024 at 15:01, 1 year 7 months ago

Press Release: Sanofi completes acquisition of Inhibrx, Inc.
Sanofi completes acquisition of Inhibrx, Inc., adding SAR447537 to rare disease pipeline. Former Inhibrx shareholders receive $30.00 per share in cash and one contingent value right. Inhibrx Biosciences begins trading on NASDAQ as INXB

Acquisition Nasdaq Sanofi Inhibrx SAR447537
BRIEF

published on 05/27/2024 at 07:05, 1 year 7 months ago

FDA Grants Priority Review to Sarclisa for Treatment of Multiple Myeloma

FDA Sanofi Multiple Myeloma Sarclisa Chemotherapy
BRIEF

published on 05/21/2024 at 07:35, 1 year 7 months ago

Sanofi, Formation Bio, and OpenAI Announce AI Collaboration

Collaboration AI Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE

published on 05/21/2024 at 07:30, 1 year 7 months ago

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently

Collaboration Drug Development Sanofi OpenAI Formation Bio
BRIEF

published on 05/20/2024 at 22:59, 1 year 7 months ago

Sanofi: April 2024 Voting Rights and Shares Information

Voting Rights Shares Financial Disclosure April 2024 Sanofi
PRESS RELEASE

published on 05/20/2024 at 22:54, 1 year 7 months ago

Sanofi: Information concerning the total number of voting rights and shares - April 2024
Sanofi provides total number of issued shares and voting rights as per French Commercial Code and AMF regulations for April 30, 2024

Share Capital Voting Rights French Commercial Code AMF Regulations Sanofi

Accesswire

Published on 01/10/2026 at 05:10, 17 hours 28 minutes ago

Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 21 hours 53 minutes ago

Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 23 hours 8 minutes ago

Sun Peak Metals Grants Stock Options
Published on 01/09/2026 at 23:30, 23 hours 8 minutes ago

Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 23 hours 28 minutes ago

Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE

EQS Group

Published on 01/10/2026 at 21:25, 1 hour 13 minutes ago

CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 9 hours 33 minutes ago

SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 1 day ago

Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 1 day 4 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:19, 1 day 4 hours ago

EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG

Les Echos

Published on 01/09/2026 at 18:30, 1 day 4 hours ago

H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 1 day 4 hours ago

January 2026
Published on 01/09/2026 at 17:45, 1 day 4 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 1 day 4 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 2 days 1 hour ago

Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE